Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00640705 · ClinicalTrials.gov registry record · Phase 2
Diclofenac Patch for Treatment of Mild to Moderate Ankle Sprain
A Phase 2 study, sponsored by Cerimon Pharmaceuticals.
- Terminated
- Registry status
- Phase 2
- Development phase
- 170
- Enrollment target
NCT00640705: Clinical Trial Phase 2 study, sponsored by Cerimon Pharmaceuticals.
NCT00640705 is a Phase 2 study that was terminated before completion, run by Cerimon Pharmaceuticals. The registered enrollment target is 170 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (28% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00640705, a Phase 2 study, was terminated before completion, sponsored by Cerimon Pharmaceuticals.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 170 participants
- Enrollment target
Study Summary
The primary purpose of this study is to assess the effectiveness of once daily application of a diclofenac sodium patch to the skin near or over the painful area. In this study, the location being studied will be either the left or right ankle. The secondary purpose of this study is to assess the safety and tolerability of a diclofenac patch on the skin.
Interventions
- DRUG diclofenac sodium
- DRUG Matching placebo patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2008-01 |
| Est. Completion | 2008-10 |
| Phase | Phase 2 |
Why NCT00640705 stopped before completion
NCT00640705 is an interventional study that assigns participants to a tested intervention. The registered 170 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (28% higher).
The record links to 0 conditions, and to 2 interventions - of which diclofenac sodium is the first listed.
NCT00640705 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00640705 about?
NCT00640705 is a clinical study titled "Diclofenac Patch for Treatment of Mild to Moderate Ankle Sprain". The primary purpose of this study is to assess the effectiveness of once daily application of a diclofenac sodium patch to the skin near or over the painful area. In this study, the location being studied will be either the left or right ankle. The secondary purpose of this study is to assess the s...
What is the current status of trial NCT00640705?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 170 participants. The study started on 2008-01. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00640705?
The interventions under investigation include: diclofenac sodium (DRUG), Matching placebo patch (DRUG).
Who is sponsoring clinical trial NCT00640705?
This trial is sponsored by Cerimon Pharmaceuticals, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00640705's enrollment target sits among peer trials
170 399th of 2000 higher than 1,598 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02016430 · 170 participants · NA
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
- NCT02621021 · 170 participants · Phase 2
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- NCT04094701 · 170 participants · NA
Hip Arthroscopy Postoperative Opioid Demands
- NCT04166409 · 170 participants · Phase 3
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia